In This Article:
- By insider
CEO of Moderna Inc (30-Year Financial, Insider Trades) Stephane Bancel (insider trades) sold 9,000 shares of MRNA on 02/10/2021 at an average price of $182.74 a share. The total sale was $1.6 million.
Moderna Inc has a market cap of $72.59 billion; its shares were traded at around $183.440000 with and P/S ratio of 286.62. GuruFocus has detected 5 severe warning signs with Moderna Inc. .
CEO Recent Trades:
-
CEO Stephane Bancel sold 9,000 shares of MRNA stock on 02/10/2021 at the average price of $182.74. The price of the stock has increased by 0.38% since.
-
CEO Stephane Bancel sold 11,046 shares of MRNA stock on 02/05/2021 at the average price of $174.61. The price of the stock has increased by 5.06% since.
-
CEO Stephane Bancel sold 19,000 shares of MRNA stock on 02/04/2021 at the average price of $161.73. The price of the stock has increased by 13.42% since.
-
CEO Stephane Bancel sold 11,046 shares of MRNA stock on 01/29/2021 at the average price of $173.25. The price of the stock has increased by 5.88% since.
-
CEO Stephane Bancel sold 19,000 shares of MRNA stock on 01/28/2021 at the average price of $152.76. The price of the stock has increased by 20.08% since.
Directors and Officers Recent Trades:
-
Chief Medical Officer Tal Zvi Zaks sold 3,670 shares of MRNA stock on 02/08/2021 at the average price of $184.56. The price of the stock has decreased by 0.61% since.
-
See remarks Juan Andres sold 5,000 shares of MRNA stock on 02/08/2021 at the average price of $176.98. The price of the stock has increased by 3.65% since.
-
President Stephen Hoge sold 20,000 shares of MRNA stock on 02/03/2021 at the average price of $157.46. The price of the stock has increased by 16.5% since.
-
See remarks Juan Andres sold 5,000 shares of MRNA stock on 02/01/2021 at the average price of $172.99. The price of the stock has increased by 6.04% since.
-
Chief Medical Officer Tal Zvi Zaks sold 5,000 shares of MRNA stock on 02/01/2021 at the average price of $162.34. The price of the stock has increased by 13% since.
For the complete insider trading history of MRNA, click here
.This article first appeared on GuruFocus.